Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Cooper

Showing results (251-260 of 363) with videos related to

Pageof 37
Sort By:
AIDS (London, England)|March 1, 1991
Sulphadiazine desensitization in patients with AIDS and cerebral toxoplasmosisM Tenant-Flowers, M J Boyle, D Carey, et al.
Lancet (London, England)|October 10, 1992
Long-term symptomless HIV-1 infection in recipients of blood products from a single donorJ Learmont, B Tindall, L Evans, et al.
The Journal of Infectious Diseases|November 17, 1998
Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study GroupG R Kaufmann, P Cunningham, A D Kelleher, et al.
British Journal of Haematology|December 1, 1990
Definition of two distinct types of AIDS-associated non-Hodgkin lymphomaM J Boyle, C E Swanson, J J Turner, et al.
Reproduction, Fertility, and Development|August 28, 2010
Temporal relationships of the LH surge and ovulation to echotexture and power Doppler signals of blood flow in the wall of the preovulatory follicle in heifersM A R Siddiqui, J C Ferreira, E L Gastal, et al.
HIV Medicine|July 16, 2003
HIV lipodystrophy: prevalence, severity and correlates of risk in AustraliaJ Miller, A Carr, S Emery, et al.
Virology|August 1, 1989
Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virusT B Sculley, A Apolloni, R Stumm, et al.
Irish Journal of Medical Science|April 23, 2010
Substance use among HIV patientsM B O'Connor, C O'Connor, J A Saunders, et al.
International Journal of STD & AIDS|June 23, 2009
HIV positive: who do they tell?M B O'Connor, C O'Connor, J A Saunders, et al.
Nature Medicine|December 1, 2001
HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemiaJ S Liang, O Distler, D A Cooper, et al.
Pageof 37

Showing results (251-260 of 363) with videos related to

Sort By:
Pageof 37
AIDS (London, England)|March 1, 1991
Sulphadiazine desensitization in patients with AIDS and cerebral toxoplasmosisM Tenant-Flowers, M J Boyle, D Carey, et al.
Lancet (London, England)|October 10, 1992
Long-term symptomless HIV-1 infection in recipients of blood products from a single donorJ Learmont, B Tindall, L Evans, et al.
The Journal of Infectious Diseases|November 17, 1998
Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study GroupG R Kaufmann, P Cunningham, A D Kelleher, et al.
British Journal of Haematology|December 1, 1990
Definition of two distinct types of AIDS-associated non-Hodgkin lymphomaM J Boyle, C E Swanson, J J Turner, et al.
Reproduction, Fertility, and Development|August 28, 2010
Temporal relationships of the LH surge and ovulation to echotexture and power Doppler signals of blood flow in the wall of the preovulatory follicle in heifersM A R Siddiqui, J C Ferreira, E L Gastal, et al.
HIV Medicine|July 16, 2003
HIV lipodystrophy: prevalence, severity and correlates of risk in AustraliaJ Miller, A Carr, S Emery, et al.
Virology|August 1, 1989
Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virusT B Sculley, A Apolloni, R Stumm, et al.
Irish Journal of Medical Science|April 23, 2010
Substance use among HIV patientsM B O'Connor, C O'Connor, J A Saunders, et al.
International Journal of STD & AIDS|June 23, 2009
HIV positive: who do they tell?M B O'Connor, C O'Connor, J A Saunders, et al.
Nature Medicine|December 1, 2001
HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemiaJ S Liang, O Distler, D A Cooper, et al.
Pageof 37